Stock Taper
EXCHANGE TRADED FUND

SURI

Simplify Propel Opportunities ETF
$20.20 ▼ 1.61%
−$0.33 TODAY

FUND FACTS

Manager Simplify
Assets $87.99M
Expense ratio 2.82%
Inception Feb 7, 2023
Asset class Equity
Holdings 25
Volume 4.59K
Avg volume 6.54K

ABOUT THIS FUND

The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel, the fund's sub-advisor, applies its deep scientific and commercial knowledge in health sciences to identify and select the most promising investment opportunities within this sector.

PRICE

$20.20 ▼ DOWN 1.61% (−$0.33)
$20.20$20.30$20.40$20.509:45 AM10:46 AM11:47 AM12:47 PM1:48 PM2:49 PM3:50 PM20.20

HOLDINGS

TOP 20 OF 25 · 88.35% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 PAGP Plains GP Holdings LP 40.94% 1.27M $35.59M
02 ACHV Achieve Life Sciences, Inc. 13.34% 1.43M $11.6M
03 DCTH Delcath Systems, Inc. 4.55% 241.97K $3.95M
08 ABEO Abeona Therapeutics Inc. 1.88% 276.33K $1.64M
09 CMPS COMPASS Pathways plc 1.81% 114.28K $1.57M
10 KYTX Kyverna Therapeutics, Inc. 1.76% 182.6K $1.53M
11 IVA Inventiva S.A. 1.70% 313.48K $1.47M
13 LONA LeonaBio, Inc. 1.34% 149.28K $1.17M
15 CLDX Celldex Therapeutics, Inc. 1.30% 28.84K $1.13M
16 ARTV Artiva Biotherapeutics, Inc. 1.29% 101.36K $1.12M
17 PALI Palisade Bio, Inc. 1.00% 434.33K $868.67K
18 OCUL Ocular Therapeutix, Inc. 0.97% 81.05K $839.69K
19 IMUX Immunic, Inc. 0.54% 30.73K $473.17K
20 UPB Upstream Bio, Inc. 0.48% 62.11K $415.54K

SECTOR HOLDINGS

TECHNOLOGY IS 52.08% OF THE FUND
Healthcare 52.08%
Energy 47.92%

BY REGION

UNITED STATES IS 81.36% OF THE FUND
United States 81.36%
Other 10.67%
Canada 4.47%
United Kingdom 1.80%
France 1.70%